SCHEMBL2840148

SCHEMBL2840148

CN1CCc2ccsc2C(Oc2ccccc2Br)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 9/20 0.41
DRD5 P21918 6/20 0.41
DRD2 P14416 4/20 0.41
DRD3 P35462 3/20 0.41
DRD4 P21917 2/20 0.41
SSTR1 P30872 1/20 0.36
SSTR4 P31391 1/20 0.36
CYP2D6 P10635 2/20 0.36
CYP1A2 P05177 1/20 0.36
TSHR P16473 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ADCY2 Q08462 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
LMNA P02545 2/20 0.35
ADRA2A P08913 2/20 0.35
ADRA2B P18089 2/20 0.35
ADRA2C P18825 2/20 0.35
SLC6A2 P23975 2/20 0.35
HTR2A P28223 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2841618 0.89 DRD1 (0.35) DRD1DRD5DRD2DRD3DRD4
SCHEMBL2837042 0.85 SIGMAR1 (0.36) DRD1DRD5TSHRCYP2C19SIGMAR1
SCHEMBL2845609 0.83 MEN1 (0.41) DRD1DRD5DRD2DRD3DRD4
SCHEMBL2872457 0.81 HHAT (0.40) DRD1DRD5DRD2DRD3DRD4
SCHEMBL2845450 0.78 DRD1 (0.37) DRD1DRD5DRD2HTR2AHTR2C
SCHEMBL2841105 0.78 IMPDH2 (0.41) DRD1DRD5DRD2DRD3DRD4
SCHEMBL4752619 0.77 DRD2 (0.43) DRD1DRD5DRD2DRD3DRD4
SCHEMBL2838274 0.74 SIGMAR1 (0.34) SIGMAR1SLC6A4
SCHEMBL2842497 0.74 SLC6A2 (0.38) CYP2D6LMNASLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL2841676 0.72 SLC6A2 (0.39) DRD2DRD3DRD4CYP2D6SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 DRD1 40/4885DRD5 287/4885DRD2 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.